skip to main content
Language:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters

Results 1 - 20 of 699,979  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The Unequal Pandemic: COVID-19 and Health Inequalities
Material Type:
Book
Add to My Research

The Unequal Pandemic: COVID-19 and Health Inequalities

Bristol University Press ;Bristol University Press 2021 ;ISBN: 9781447361237 ;ISBN: 1447361237 ;ISBN: 1447361253 ;ISBN: 9781447361251 ;EISBN: 1447361253 ;EISBN: 9781447361244 ;EISBN: 1447361245 ;EISBN: 9781447361251 ;DOI: 10.46692/9781447361251 ;OCLC: 1257077799

Full text available

2
COVID-19 in the Environment: Impact, Concerns, and Management of Coronavirus
Material Type:
Book
Add to My Research

COVID-19 in the Environment: Impact, Concerns, and Management of Coronavirus

ISBN: 0323902723 ;ISBN: 9780323902724 ;EISBN: 9780323902731 ;EISBN: 0323902731 ;DOI: 10.1016/C2020-0-03518-8 ;OCLC: 1269096029

Full text available

3
BNT162b vaccines protect rhesus macaques from SARS-CoV-2
Material Type:
Article
Add to My Research

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

Nature (London), 2021-04, Vol.592 (7853), p.283-289 [Peer Reviewed Journal]

Copyright Nature Publishing Group Apr 8, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03275-y ;PMID: 33524990

Full text available

4
Correction: Evolution and consequences of individual responses during the COVID-19 outbreak
Material Type:
Article
Add to My Research

Correction: Evolution and consequences of individual responses during the COVID-19 outbreak

PloS one, 2023-10, Vol.18 (10), p.e0292775-e0292775 [Peer Reviewed Journal]

COPYRIGHT 2023 Public Library of Science ;2023 Abbas et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Abbas et al 2023 Abbas et al ;2023 Abbas et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0292775

Full text available

5
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
Material Type:
Article
Add to My Research

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

BMJ (Online), 2021-05, Vol.373, p.n1088-n1088 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n1088 ;PMID: 33985964

Full text available

6
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Material Type:
Article
Add to My Research

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

Nature (London), 2021-05, Vol.593 (7857), p.130-135 [Peer Reviewed Journal]

Copyright Nature Publishing Group May 6, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03398-2 ;PMID: 33684923

Full text available

7
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
Material Type:
Article
Add to My Research

SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact

Nature reviews. Immunology, 2022-01, Vol.22 (1), p.57-65 [Peer Reviewed Journal]

2021. Springer Nature Limited. ;COPYRIGHT 2022 Nature Publishing Group ;Springer Nature Limited 2021. ;Springer Nature Limited 2021 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-021-00662-4 ;PMID: 34876702

Full text available

8
Correction: Predictors of post-COVID symptoms in Egyptian patients: Drugs used in COVID-19 treatment are incriminated
Material Type:
Article
Add to My Research

Correction: Predictors of post-COVID symptoms in Egyptian patients: Drugs used in COVID-19 treatment are incriminated

PloS one, 2022-07, Vol.17 (7), p.e0271154-e0271154 [Peer Reviewed Journal]

COPYRIGHT 2022 Public Library of Science ;2022 The PLOS ONE Staff 2022 The PLOS ONE Staff ;2022 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0271154 ;PMID: 35789344

Full text available

9
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
Material Type:
Article
Add to My Research

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

Nature medicine, 2021-11, Vol.27 (11), p.2032-2040 [Peer Reviewed Journal]

2021. The Author(s). ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01540-1 ;PMID: 34588689

Full text available

10
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
Material Type:
Article
Add to My Research

Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data

The Lancet (British edition), 2021-05, Vol.397 (10289), p.2043-2046 [Peer Reviewed Journal]

2021 Elsevier Ltd ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01115-6 ;PMID: 33991480

Full text available

11
Challenges for COVID-19 Vaccination Delivery and Data Interoperability In Smaller Independent Primary Care Practices
Material Type:
Conference Proceeding
Add to My Research

Challenges for COVID-19 Vaccination Delivery and Data Interoperability In Smaller Independent Primary Care Practices

Annals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]

2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.4767

Full text available

12
Scoping Review of COVID-19 Vaccination Models for Refugees
Material Type:
Conference Proceeding
Add to My Research

Scoping Review of COVID-19 Vaccination Models for Refugees

Annals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]

2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.4935

Full text available

13
Exploiting administrative claims data through modelling and creativity: Epidemiology of Post Covid Syndrome
Material Type:
Conference Proceeding
Add to My Research

Exploiting administrative claims data through modelling and creativity: Epidemiology of Post Covid Syndrome

Annals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]

2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.5229

Full text available

14
Post-Acute Sequelae of COVID-19: Analysis of Autoantibody Abnormalities and Impact of Pain on Quality of Life and Function
Material Type:
Conference Proceeding
Add to My Research

Post-Acute Sequelae of COVID-19: Analysis of Autoantibody Abnormalities and Impact of Pain on Quality of Life and Function

Annals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]

2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.4787

Full text available

15
Factors Influencing Parental Intent to Vaccinate Children Against COVID-19 in the United States
Material Type:
Conference Proceeding
Add to My Research

Factors Influencing Parental Intent to Vaccinate Children Against COVID-19 in the United States

Annals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]

2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.4732

Full text available

16
Impact of the COVID-19 Pandemic on Attendance at the 18-month-old Developmental Screening Visit
Material Type:
Conference Proceeding
Add to My Research

Impact of the COVID-19 Pandemic on Attendance at the 18-month-old Developmental Screening Visit

Annals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]

2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.5503

Full text available

17
Primary prevention and screening during the COVID-19 pandemic: Qualitative findings from the BETTER WISE project
Material Type:
Conference Proceeding
Add to My Research

Primary prevention and screening during the COVID-19 pandemic: Qualitative findings from the BETTER WISE project

Annals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]

2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.4973

Full text available

18
Diagnostic Phenotypes of Post-Acute Sequelae Following COVID-19 Leveraging the American Family Cohort, PRIME Registry
Material Type:
Conference Proceeding
Add to My Research

Diagnostic Phenotypes of Post-Acute Sequelae Following COVID-19 Leveraging the American Family Cohort, PRIME Registry

Annals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]

2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.5288

Full text available

19
The prevalence of post-COVID conditions in United States primary care practices in the American Family Cohort PRIME Registry
Material Type:
Conference Proceeding
Add to My Research

The prevalence of post-COVID conditions in United States primary care practices in the American Family Cohort PRIME Registry

Annals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]

2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.5285

Full text available

20
COVID-19 case counts, individual immune function and pathogen avoidance motivation
Material Type:
Conference Proceeding
Add to My Research

COVID-19 case counts, individual immune function and pathogen avoidance motivation

Annals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]

2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.4840

Full text available

Results 1 - 20 of 699,979  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (371,228)

Refine My Results

Creation Date 

From To
  1. Before 1999  (15)
  2. 1999 To 2009  (10)
  3. 2010 To 2014  (21)
  4. 2015 To 2020  (216,995)
  5. After 2020  (482,611)
  6. More options open sub menu

Resource Type 

  1. Articles  (528,660)
  2. Newspaper Articles  (76,407)
  3. magazinearticle  (68,656)
  4. Reports  (9,175)
  5. Newsletter Articles  (3,005)
  6. Thesises (postgraduate)  (2,974)
  7. Reviews  (2,314)
  8. Books  (1,700)
  9. Datasets  (1,431)
  10. Conference Proceedings  (1,397)
  11. Web Resources  (1,337)
  12. Images  (1,139)
  13. Text Resources  (998)
  14. Book Chapters  (452)
  15. Archival Material / Manuscripts  (122)
  16. Audio  (96)
  17. Standards  (52)
  18. Videos  (27)
  19. Other  (15)
  20. Computer Files  (9)
  21. More options open sub menu

Language 

  1. English  (681,141)
  2. Japanese  (15,968)
  3. Spanish  (10,242)
  4. Portuguese  (9,556)
  5. French  (3,551)
  6. German  (3,544)
  7. Russian  (1,916)
  8. Indonesian  (1,316)
  9. Turkish  (1,150)
  10. Chinese  (1,039)
  11. Norwegian  (942)
  12. Catalan  (825)
  13. Finnish  (821)
  14. Persian  (778)
  15. Czech  (564)
  16. Korean  (497)
  17. Polish  (363)
  18. Croatian  (360)
  19. Arabic  (349)
  20. Italian  (308)
  21. More options open sub menu

Searching Remote Databases, Please Wait